Skip to main content
. 2021 Mar 25;26(7):1838. doi: 10.3390/molecules26071838

Figure 4.

Figure 4

Figure 4

(a) Non-covalent interactions of erlotinib inside the EGFR active site; (b) 2D schematic representation of erlotinib inside the EGFR binding site; (c) non-covalent interactions of docked compound 4g inside the EGFR active site; (d) 2D schematic representation of compound 4g inside the EGFR binding site.